Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Phreesia, Inc. Stock Research

PHR

19.38USD+0.27(+1.41%)Delayedas of 20 Sep 2023, 02:36 pm
Watchlist

Market Summary

USD19.38+0.27
Delayedas of 20 Sep 2023, 02:36 pm
1.41%

PHR Alerts

  • 1 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Losses in recent quarter

PHR Stock Price

PHR RSI Chart

PHR Valuation

Market Cap

1.0B

Price/Earnings (Trailing)

-6.69

Price/Sales (Trailing)

3.19

EV/EBITDA

-7.27

Price/Free Cashflow

-15.97

PHR Price/Sales (Trailing)

PHR Profitability

EBT Margin

-53.71%

Return on Equity

-61.62%

Return on Assets

-45.9%

Free Cashflow Yield

-6.26%

PHR Fundamentals

PHR Revenue

Revenue (TTM)

319.4M

Revenue Y/Y

26.47%

Revenue Q/Q

2.37%

PHR Earnings

Earnings (TTM)

-152.5M

Earnings Y/Y

21.3%

Earnings Q/Q

2.04%

Price Action

52 Week Range

18.7740.00
(Low)(High)

Last 7 days

-10.2%

Last 30 days

-29.6%

Last 90 days

-37.6%

Trailing 12 Months

-30.3%

PHR Financial Health

Current Ratio

2.89

Debt/Equity

0.03

Debt/Cashflow

-10.49

PHR Investor Care

Shares Dilution (1Y)

2.71%

Diluted EPS (TTM)

-2.86

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for PHR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-14
VanDuyn Amy Beth
sold
-40,315
20.1579
-2,000
svp, human resources
2023-09-14
Hoffman Allison C
sold
-44,566
20.1656
-2,210
general counsel & secretary
2023-09-14
Davidoff Michael J.
sold
-59,537
20.1616
-2,953
svp, payer business
2023-09-13
Indig Chaim
sold
-133,323
20.3391
-6,555
chief executive officer
2023-09-13
VanDuyn Amy Beth
sold
-37,139
20.3391
-1,826
svp, human resources
2023-09-13
Gunzburg Janet
sold
-18,996
20.3388
-934
principal accounting officer
2023-09-13
Gandhi Balaji
sold
-80,481
20.3391
-3,957
chief financial officer
2023-09-13
Roberts Evan
sold
-79,464
20.3391
-3,907
chief operating officer
2023-09-13
Davidoff Michael J.
sold
-73,342
20.3391
-3,606
svp, payer business
2023-09-13
Linetsky David
sold
-2,420
20.341
-119
svp, life sciences

1–10 of 50

Which funds bought or sold PHR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-31.58
-11,146
21,361
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-1.16
-102,284
1,910,060
-%
2023-08-18
Legato Capital Management LLC
added
39.37
222,401
879,599
0.12%
2023-08-16
Nuveen Asset Management, LLC
reduced
-58.28
-12,029,400
8,040,580
-%
2023-08-15
ZACKS INVESTMENT MANAGEMENT
added
86.86
762,699
1,722,680
0.01%
2023-08-15
GOLDMAN SACHS GROUP INC
reduced
-31.97
-4,435,110
8,357,290
-%
2023-08-15
CAPTRUST FINANCIAL ADVISORS
sold off
-100
-248,893
-
-%
2023-08-15
WELLS FARGO & COMPANY/MN
added
104
425,122
866,151
-%
2023-08-15
LAZARD ASSET MANAGEMENT LLC
reduced
-0.09
-349,000
8,290,000
0.01%
2023-08-15
Belpointe Asset Management LLC
sold off
-100
-12,755
-
-%

1–10 of 45

Latest Funds Activity

Are funds buying PHR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PHR
No. of Funds

Schedule 13G FIlings of Phreesia

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
t. rowe price investment management, inc.
5.1%
2,676,879
SC 13G
Feb 14, 2023
price t rowe associates inc /md/
0.3%
180,384
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
brown advisory inc
5.8%
3,068,782
SC 13G
Feb 09, 2023
vanguard group inc
7.34%
3,872,425
SC 13G/A
Jan 25, 2023
blackrock inc.
8.7%
4,564,585
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
15.2%
7,797,879
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 07, 2022
blackrock inc.
11.7%
6,010,340
SC 13G/A
May 10, 2021
price t rowe associates inc /md/
10.7%
5,402,206
SC 13G/A

Recent SEC filings of Phreesia

View All Filings
Date Filed Form Type Document
Sep 18, 2023
144
Notice of Insider Sale Intent
Sep 18, 2023
144
Notice of Insider Sale Intent
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading
Sep 14, 2023
4
Insider Trading

Peers (Alternatives to Phreesia)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
445.6B
348.5B
-3.57% -7.58%
21.11
1.28
13.69% 15.63%
33.5B
2.2B
12.06% 21.42%
62
15
11.56% 37.20%
MID-CAP
3.4B
2.5B
-10.21% -31.13%
-0.85
1.35
13.30% 59.30%
2.5B
1.2B
-6.17% -41.00%
-106.97
2.01
-1.77% -138.27%
SMALL-CAP
1.6B
678.1M
46.14% 40.83%
673.85
2.34
12.34% 2970.73%
1.4B
-
-1.07% -22.58%
22.47
1.63
- -
1.0B
319.4M
-29.59% -30.26%
-6.69
3.19
30.27% 15.64%
848.8M
2.4B
-3.77% -18.89%
6.82
0.35
-5.09% -42.39%
815.2M
55.7M
-11.62% -23.93%
78.48
14.64
7.05% -12.17%
654.2M
274.0M
-1.02% -2.78%
50.83
2.39
5.60% 81.56%
582.9M
284.6M
-13.51% 0.59%
-3.96
2.05
7.33% -1.68%
279.0M
338.1M
0.49% 104.56%
-2.92
0.83
22.28% 17.91%
141.3M
61.6M
-11.20% -48.63%
-9.85
2.3
-4.03% -105.54%

Phreesia News

Simply Wall St
This Insider Has Just Sold Shares In Phreesia.
Simply Wall St,
8 hours ago
Investing.com UK
Zacks Investment Research

Returns for PHR

Cumulative Returns on PHR

-13.8%


3-Year Cumulative Returns

Risks for PHR

What is the probability of a big loss on PHR?

84.1%


Probability that Phreesia stock will be more than 20% underwater in next one year

75%


Probability that Phreesia stock will be more than 30% underwater in next one year.

69.5%


Probability that Phreesia stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PHR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Phreesia was unfortunately bought at previous high price.

Drawdowns

Financials for Phreesia

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue6.0%319,364,000301,401,000280,910,000262,344,000245,156,000228,296,000213,233,000197,021,000179,570,000163,572,000148,677,000139,684,000134,063,000129,871,000124,785,000118,453,000110,366,000104,328,00099,889,00097,874,66797,300,000
  S&GA Expenses-0.7%147,548,000148,645,000151,263,000152,209,000147,614,000131,440,000106,421,00082,174,00060,619,00048,550,00042,972,00038,200,00036,067,00034,089,00032,357,00030,566,00029,413,00027,821,93026,367,00027,447,86026,115,720
  R&D Expenses5.1%102,007,00097,078,00091,244,00083,341,00075,945,00064,846,00052,265,00041,125,00031,584,00025,671,00022,622,00021,128,00020,170,00019,330,00018,623,00017,968,00017,050,00015,538,92114,349,00014,069,84212,715,684
EBITDA100.0%--137,821,000-149,295,000-164,403,000-162,125,000-140,247,000-97,761,000-64,016,000-35,798,000-16,323,000-12,908,000-11,025,000-7,146,000-9,236,002-10,594,000------
EBITDA Margin100.0%--0.46-0.53-0.63-0.66-0.61-0.46-0.32-0.20-0.10-0.09-0.08-0.05-0.07-0.08------
Interest Expenses-100.0%-2,165,0001,064,000-856,000-1,228,000-1,229,000-1,084,000-1,123,000-1,279,000-1,491,000-1,573,000-1,882,000-1,634,000-1,960,000-2,445,000-2,813,000-3,322,000-3,460,673-3,504,000-3,223,346-3,534,692
Earnings Before Taxes6.4%-151,497,000-161,881,000-175,663,000-184,355,000-180,559,000-158,161,000-117,979,000-79,513,000-49,867,000-32,067,000-27,243,000-24,456,000-20,310,000-21,447,000-22,073,000-21,521,000-23,320,000-18,464,950-15,062,000-13,517,900-10,347,800
EBT Margin100.0%--0.54-0.63-0.70-0.74-0.69-0.55-0.40-0.28-0.20-0.18-0.18-0.15-0.17-0.18------
Net Income6.1%-152,486,000-162,435,000-176,146,000-184,576,000-180,752,000-158,429,000-118,161,000-79,806,000-50,176,000-32,154,000-27,292,000-22,864,000-18,588,000-19,710,000-20,293,000-21,705,000-23,440,000-18,534,000-15,063,000-13,310,666-11,622,000
Net Income Margin100.0%--0.54-0.63-0.70-0.74-0.69-0.55-0.41-0.28-0.20-0.18-0.16-0.14-0.15-0.16------
Free Cashflow100.0%--74,443,000-94,855,000-118,055,000-132,008,000-119,092,000-93,130,000-54,051,000-20,404,000-17,793,000-8,351,000-8,542,000-11,198,237-6,922,000-6,189,000------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q12018Q1
Assets-3.8%34035437039742645949452955156132733816016115915616359.0057.00
  Current Assets-8.7%21924026228731634938646449450727230312813013212913633.0036.00
    Cash Equivalents-14.7%12815017721024126931440044045121925484.0090.0090.0091.001002.0011.00
  Net PPE-----------27.0019.0017.0015.0014.0014.0015.0014.0013.00
  Goodwill20.4%41.0034.0034.0034.0034.0034.0034.008.008.008.008.000.000.000.000.000.000.000.00-
Liabilities3.5%93.0090.0082.0077.0078.0078.0077.0071.0065.0058.0063.0068.0063.0061.0057.0053.0060.0064.0049.00
  Current Liabilities2.3%85.0083.0079.0073.0072.0071.0068.0065.0058.0051.0055.0042.0038.0038.0035.0032.0039.0028.0025.00
  Long Term Debt20.4%8.007.003.004.005.006.007.005.006.006.006.0024.0023.00-22.00----
    LT Debt, Current------------------0.001.00
    LT Debt, Non Current--------------19.0019.0019.0019.0028.0019.00
Shareholder's Equity-6.3%24726428832034838141745848750326327098.00100102102103--
  Retained Earnings-5.7%-680-643-606-568-527-481-429-383-347-322-311-303-296-290-284-280-278-210-167
  Additional Paid-In Capital2.5%971947927912896881861849840832580574395391386383381--
Accumulated Depreciation-----------40.0043.0040.0038.0036.0034.0032.0028.0020.00
Shares Outstanding-100.0%-53.00-53.0052.0052.00-51.0051.0045.0045.0039.0038.0037.0037.0036.007.002.002.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations15.0%-59.64-70.15-90.12-112-115-102-74.71-32.65-8.79-4.493.000.00-2.281.001.00-4.25-0.49-1.39-2.133.002.00
  Share Based Compensation6.6%66.0062.0059.0054.0052.0045.0036.0030.0020.0016.0013.0012.0010.008.006.004.003.002.001.002.001.00
Cashflow From Investing-15.3%-29.12-25.26-26.20-60.27-68.05-65.35-65.23-38.54-27.74-28.91-25.08-14.27-14.08-12.67-12.32-13.04-11.80-11.85-11.02-9.12-9.72
Cashflow From Financing-1.2%-24.29-24.02-20.80-18.33-15.09-13.272352173923941511771.0096.0010010610815.004.00-1.05-4.32

PHR Income Statement

2023-07-31
Unaudited Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Jul. 31, 2023
Jul. 31, 2022
Revenue:    
Total revenues$ 85,830$ 67,867$ 169,675$ 131,221
Expenses:    
Cost of revenue (excluding depreciation and amortization)14,44914,87329,35629,259
Payment processing expense15,85212,55431,94224,712
Sales and marketing37,24438,34174,65778,372
Research and development27,47122,54253,94043,177
General and administrative20,98820,07340,86540,928
Depreciation4,2444,2208,7488,498
Amortization2,5371,5995,0233,203
Total expenses122,785114,202244,531228,149
Operating loss(36,955)(46,335)(74,856)(96,928)
Other income, net503887
Interest income (expense), net786(206)1,504(589)
Total other income (expense), net836(168)1,512(582)
Loss before provision for income taxes(36,119)(46,503)(73,344)(97,510)
Provision for income taxes(648)(213)(954)(448)
Net loss$ (36,767)$ (46,716)$ (74,298)$ (97,958)
Net loss per share attributable to common stockholders, basic (in dollars per share)$ (0.68)$ (0.89)$ (1.39)$ (1.88)
Net loss per share attributable to common stockholders, diluted (in dollars per share)$ (0.68)$ (0.89)$ (1.39)$ (1.88)
Weighted-average common shares outstanding, basic (in shares)53,794,06052,325,20953,574,58452,135,250
Weighted-average common shares outstanding, diluted (in shares)53,794,06052,325,20953,574,58452,135,250
Subscription and related services    
Revenue:    
Total revenues$ 39,301$ 31,069$ 77,188$ 60,170
Payment processing fees    
Revenue:    
Total revenues23,63119,58147,88438,962
Network solutions    
Revenue:    
Total revenues$ 22,898$ 17,217$ 44,603$ 32,089

PHR Balance Sheet

2023-07-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2023
Jan. 31, 2023
Current:  
Cash and cash equivalents$ 127,677$ 176,683
Settlement assets25,15822,599
Accounts receivable, net of allowance for doubtful accounts of $770 and $1,053 as of July 31, 2023 and January 31, 2023, respectively53,91351,394
Deferred contract acquisition costs8201,056
Prepaid expenses and other current assets11,66210,709
Total current assets219,230262,441
Property and equipment, net of accumulated depreciation and amortization of $68,044 and $59,847 as of July 31, 2023 and January 31, 2023, respectively22,81621,670
Capitalized internal-use software, net of accumulated amortization of $41,552 and $37,236 as of July 31, 2023 and January 31, 2023, respectively41,20535,150
Operating lease right-of-use assets227569
Deferred contract acquisition costs1,3701,754
Intangible assets, net of accumulated amortization of $3,256 and $2,549 as of July 31, 2023 and January 31, 2023, respectively12,99411,401
Deferred tax asset081
Goodwill40,61133,736
Other assets1,9893,255
Total Assets340,442370,057
Current:  
Settlement obligations25,15822,599
Current portion of finance lease liabilities and other debt7,1125,172
Current portion of operating lease liabilities416934
Accounts payable7,94810,836
Accrued expenses27,79421,810
Deferred revenue16,44117,688
Total current liabilities84,86979,039
Long-term finance lease liabilities and other debt8,0552,725
Operating lease liabilities, non-current216349
Long-term deferred revenue99125
Long-term deferred tax liabilities1830
Total Liabilities93,42282,238
Commitments and contingencies (Note 11)
Stockholders’ Equity:  
Common stock, $0.01 par value - 500,000,000 shares authorized as of both July 31, 2023 and January 31, 2023; 55,364,795 and 54,187,172 shares issued as of July 31, 2023 and January 31, 2023, respectively554542
Additional paid-in capital971,120926,957
Accumulated deficit(680,382)(606,084)
Treasury stock, at cost, 1,300,430 and 971,236 shares as of July 31, 2023 and January 31, 2023, respectively(44,272)(33,596)
Total Stockholders’ Equity247,020287,819
Total Liabilities and Stockholders’ Equity$ 340,442$ 370,057
Chaim Indig
1700
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.